Clinical trial
MDR - Feasibility Study for Instant Cardiac Diagnostic and Post-operative Risk
NCT05987904 is registered in ClinicalTrials.gov with Lynx Health Science GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MDR - Feasibility Study for Instant Cardiac Diagnostic and Post-operative Risk
- Lead sponsor
- Lynx Health Science GmbH
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 2, 2023
- Completion date
- June 20, 2024
- Enrollment
- 1,097 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.